Retinoblastoma Genetic Screening Unit
- Retinoblastoma Genetic Screening Unit, RGSU
- Barts Health NHS Trust
- Department: Pathology/ Retinoblastoma
- 80 Newark Street, Pathology & Pharmacy Building, 3rd Floor
- Whitechapel, London, City of, United Kingdom E1 2ES
- Phone: +44 2032460265
Fax: +44 2032460321
Email: retinoblastoma.bartshealth@nhs.net - Website: http://www.eselpathology.nhs.uk/retinoblastoma
GTR Lab ID: 288934, Last updated:2024-03-04
Personnel
- Director: Zerrin Onadim, PhD, Lab Director
Phone: +44 2032460265
Fax: +44 2032460321
Email: z.onadim@nhs.net - Elizabeth Price, PhD, Clinical Scientist and Quality Lead
Phone: +44 2034165000 ext 61046
Fax: +44 2032460321
Email: retinoblastoma.bartshealth@nhs.net
Conditions and tests
List of services
- Clinical Testing/Confirmation of Mutations Identified Previously
- Confirmation of research findings
- Prenatal testing
- Custom Sequence Analysis
- Carrier testing
- DNA Banking
- Maternal cell contamination study (MCC)
- Mutation Confirmation
- Result interpretation
- Tissue Banking
List of certifications/licenses
Certifications
- UKAS, Number: 8285, Expiration date: 2024-01-31
Participation in external programs
Standardization programs
- Other
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.